These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27094132)

  • 21. Monoamine oxidase inhibitors: promising therapeutic agents for Alzheimer's disease (Review).
    Cai Z
    Mol Med Rep; 2014 May; 9(5):1533-41. PubMed ID: 24626484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Donepezil attenuates Aβ-associated mitochondrial dysfunction and reduces mitochondrial Aβ accumulation in vivo and in vitro.
    Ye CY; Lei Y; Tang XC; Zhang HY
    Neuropharmacology; 2015 Aug; 95():29-36. PubMed ID: 25744714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The adenosine receptor affinities and monoamine oxidase B inhibitory properties of sulfanylphthalimide analogues.
    Van der Walt MM; Terre'Blanche G; Petzer A; Petzer JP
    Bioorg Chem; 2015 Apr; 59():117-23. PubMed ID: 25746740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1-N-Substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: a novel cholinesterase and selective monoamine oxidase B inhibitors for the treatment of Parkinson's and Alzheimer's diseases.
    Ucar G; Gokhan N; Yesilada A; Bilgin AA
    Neurosci Lett; 2005 Jul; 382(3):327-31. PubMed ID: 15925113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current progresses of novel natural products and their derivatives/ analogs as anti-Alzheimer candidates: an update.
    Fang L; Gou S; Fang X; Cheng L; Fleck C
    Mini Rev Med Chem; 2013 May; 13(6):870-87. PubMed ID: 23305400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting monoamine oxidases with multipotent ligands: an emerging strategy in the search of new drugs against neurodegenerative diseases.
    Pisani L; Catto M; Leonetti F; Nicolotti O; Stefanachi A; Campagna F; Carotti A
    Curr Med Chem; 2011; 18(30):4568-87. PubMed ID: 21864289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, Synthesis and in vitro Evaluation of Indolotacrine Analogues as Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease.
    Benek O; Soukup O; Pasdiorova M; Hroch L; Sepsova V; Jost P; Hrabinova M; Jun D; Kuca K; Zala D; Ramsay RR; Marco-Contelles J; Musilek K
    ChemMedChem; 2016 Jun; 11(12):1264-9. PubMed ID: 26427608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and evaluation of frentizole-based indolyl thiourea analogues as MAO/ABAD inhibitors for Alzheimer's disease treatment.
    Hroch L; Guest P; Benek O; Soukup O; Janockova J; Dolezal R; Kuca K; Aitken L; Smith TK; Gunn-Moore F; Zala D; Ramsay RR; Musilek K
    Bioorg Med Chem; 2017 Feb; 25(3):1143-1152. PubMed ID: 28082069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comprehensive review on synthesis and designing aspects of coumarin derivatives as monoamine oxidase inhibitors for depression and Alzheimer's disease.
    Patil PO; Bari SB; Firke SD; Deshmukh PK; Donda ST; Patil DA
    Bioorg Med Chem; 2013 May; 21(9):2434-50. PubMed ID: 23517722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Novel Antipsychotics on Energy Metabolism - In Vitro Study in Pig Brain Mitochondria.
    Ľupták M; Fišar Z; Hroudová J
    Mol Neurobiol; 2021 Nov; 58(11):5548-5563. PubMed ID: 34365585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Monoamine oxidase as a target for drug action].
    Drozak J; Kozłowski M
    Postepy Hig Med Dosw (Online); 2006; 60():498-515. PubMed ID: 17060892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic potentials of herbal drugs for Alzheimer’s disease—An overview.
    Kumar A; Singh A; Aggarwal A
    Indian J Exp Biol; 2017 Feb; 55(2):63-73. PubMed ID: 30183230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoamine oxidase-A physically interacts with presenilin-1(M146V) in the mouse cortex.
    Wei Z; Gabriel GG; Rui L; Cao X; Pennington PR; Chlan-Fourney J; Nazarali AJ; Baker GB; Mousseau DD
    J Alzheimers Dis; 2012; 28(2):403-22. PubMed ID: 22045496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoamine oxidase-B inhibition in Alzheimer's disease.
    Riederer P; Danielczyk W; Grünblatt E
    Neurotoxicology; 2004 Jan; 25(1-2):271-7. PubMed ID: 14697902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multifunctional coumarin derivatives: monoamine oxidase B (MAO-B) inhibition, anti-β-amyloid (Aβ) aggregation and metal chelation properties against Alzheimer's disease.
    Huang M; Xie SS; Jiang N; Lan JS; Kong LY; Wang XB
    Bioorg Med Chem Lett; 2015 Feb; 25(3):508-13. PubMed ID: 25542589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial Abeta: a potential cause of metabolic dysfunction in Alzheimer's disease.
    Chen X; Yan SD
    IUBMB Life; 2006 Dec; 58(12):686-94. PubMed ID: 17424907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, biological assessment and molecular modeling of new multipotent MAO and cholinesterase inhibitors as potential drugs for the treatment of Alzheimer's disease.
    Samadi A; Chioua M; Bolea I; de Los Ríos C; Iriepa I; Moraleda I; Bastida A; Esteban G; Unzeta M; Gálvez E; Marco-Contelles J
    Eur J Med Chem; 2011 Sep; 46(9):4665-8. PubMed ID: 21669479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alzheimer's disease: the pharmacological pathway.
    Allain H; Bentué-Ferrer D; Tribut O; Gauthier S; Michel BF; Drieu-La Rochelle C
    Fundam Clin Pharmacol; 2003 Aug; 17(4):419-28. PubMed ID: 12914543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multi-target tacrine-coumarin hybrids: cholinesterase and monoamine oxidase B inhibition properties against Alzheimer's disease.
    Xie SS; Wang X; Jiang N; Yu W; Wang KD; Lan JS; Li ZR; Kong LY
    Eur J Med Chem; 2015 May; 95():153-65. PubMed ID: 25812965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural multi-target modulators of pathological pathways in Alzheimer's disease isolated from the
    Spinelli R; Rietmann Á; Sanchis I; Siano ÁS
    Nat Prod Res; 2022 Jun; 36(12):3193-3197. PubMed ID: 34311633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.